VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

AACR 2021 | Optimal application of PD-L1 IHC tests

Emina E. Torlakovic, PhD, MD, FCAP, University of Saskatchewan, Saskatoon, Canada, discusses the optimal use of PD-L1 immunohistochemistry (IHC) tests, suggesting high value in the early stages of clinical trial design when biomarkers have not yet been defined. This interview took place at the virtual American Association for Cancer Research (AACR) Annual Meeting 2021.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter